ENOBRenovaro Inc.


$ 0.69 $ 0.03 (4.01 %)    

Friday, 23-Aug-2024 14:14:17 EDT
QQQ $ 479.76 $ 5.15 (1.08 %)
DIA $ 411.97 $ 4.35 (1.07 %)
SPY $ 562.00 $ 5.91 (1.06 %)
TLT $ 98.37 $ 0.64 (0.65 %)
GLD $ 231.99 $ 2.65 (1.16 %)
$ 0.6846
$ 0.70 x 100
-- x --
-- - --
$ 0.42 - $ 5.25
125,388
na
na
$ 0.66
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Cutting-edge AI/machine learning technology with validation in humans for early diagnosis of lung cancerIn silico detection for...

 why-immucell-are-trading-higher-here-are-20-stocks-moving-premarket

Gainers Cadrenal Therapeutics, Inc. (NASDAQ: CVKD) shares surged 131.6% to $4.03 in pre-market trading after gaining 15% on ...

 why-li-auto-shares-are-trading-higher-by-around-7-here-are-other-stocks-moving-in-mondays-session

Gainers PolyMet Mining Corp. (NYSE: PLM) shares surged 144% to $1.92 after the company announced Glencore made a non-binding...

 stocks-that-hit-52-week-lows-on-tuesday

  On Tuesday, 32 companies reached new 52-week lows.

 stocks-that-hit-52-week-lows-on-tuesday

  During Tuesday's morning session, 137 companies made new 52-week lows.

 stocks-that-hit-52-week-lows-on-friday

  Friday's session saw 75 companies set new 52-week lows.

 stocks-that-hit-52-week-lows-on-monday

  During Monday's session, 49 companies made new 52-week lows.

 enochian-biosciences-announces-receipt-of-notice-from-nasdaq-regarding-delayed-filing-of-form-10-q-for-period-ended-september-30-2022

On November 23, 2022, Enochian BioSciences Inc. (the "Company") received a notice (the "Notice") from The Nasda...

 enochian-biosciences-forges-ahead-with-focused-approach-promising-future

(NASDAQ:ENOB)—Enochian BioSciences (the Company) recently announced significant progress toward re-prioritizing its focus on cu...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION